Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CEP164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUP153 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNCG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGFOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FANCD2OS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLU7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD40LG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDLIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on